EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A coordinated biomaterial strategy for post-infarction cardiac repair: integrating tailored mechanical reinforcement with hiPSC-derived cardiomyocytes in composite engineered human myocardium for remuscularization

Kiera D Dwyer, Arvin H Soepriatna, Caroline A Snyder, Anthony Callanan, Kareen L K Coulombe

Biomaterials · 2026-04 · 327 · 123727

DOI: 10.1016/j.biomaterials.2025.123727 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials, 2026-04. Verfasst von Kiera D Dwyer und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Engineering, Institute for Biology, Engineering, and Medicine, Brown University, Providence, RI, 02912, United States. Hauptthemen laut MEDLINE: Myocardial Infarction, Myocytes, Cardiac, Induced Pluripotent Stem Cells, Tissue Engineering. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, National Heart Lung and Blood Institute Division of Intramural Research, UK Research and Innovation Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Up to 1 billion cardiomyocytes (CMs) die during myocardial infarction (MI), leading to permanent muscle loss and devasting functional impacts. Biomaterial therapies have aimed to passively reinforce the infarcted left ventricle (LV), but their therapeutic impact remains limited as they fail to directly address the loss of functional CMs. In this work, we employed a simulation-guided workflow to design an optimized biomaterial support that can be combined with contractile CMs for implantation after MI. A finite element model (FEM) of the LV post-MI was developed and showed longitudinal reinforcement and active contractility improves ejection fraction (EF) post-MI (+3.39 % and +14.97 %, respectively). To this end, we developed a coordinated remuscularization-reinforcement therapy using engineered human myocardium (EHM) composed of human induced pluripotent stem cell-derived CMs (hiPSC-CMs) integrated with a highly aligned electrospun polycaprolactone (PCL) scaffold. Remuscularization (EHM-only), reinforcement (PCL-only) and its coordinated therapy (PCL-EHM) were evaluated in a rat model of MI. We report successful engraftment of the implants onto the heart with significant maturation of hiPSC-CMs after four weeks in vivo (∼7-fold increase of cTnT area and ∼2-fold increase MLC2v area compared to in vitro cultured controls). Using 4D ultrasound (US), we quantified 3D regional strains and found that the benefits of PCL reinforcement on maintaining LV structure and function were additive with remuscularization by EHM. This additive effect was reflected inimproved regional strain after injury when PCL and EHM were delivered as a composite therapy. This work establishes a promising strategy for synergistic reinforcement and remuscularization of the infarcted heart.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionMyocytes, CardiacInduced Pluripotent Stem CellsTissue EngineeringBiocompatible MaterialsMyocardiumHumansAnimalsTissue ScaffoldsRatsPolyestersMaleRats, Sprague-DawleyFinite Element Analysis

Stichwörter der Autor:innen

3D strain mappingCardiac tissue engineeringComposite materialsHeart regenerationHuman induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs)Myocardial infarction (MI)

Substanzen

Biocompatible MaterialspolycaprolactonePolyesters

Autor:innen und Institutionen

  • School of Engineering, Institute for Biology, Engineering, and Medicine, Brown University, Providence, RI, 02912, United States.
  • Institute for Bioengineering, School of Engineering, The University of Edinburgh, Edinburgh, United Kingdom.
  • School of Engineering, Institute for Biology, Engineering, and Medicine, Brown University, Providence, RI, 02912, United States; Cardiovascular Research Center, Cardiovascular Institute, Rhode Island Hospital, Alpert Me…

Förderung

  • NHLBI NIH HHS
  • National Heart Lung and Blood Institute Division of Intramural Research
  • UK Research and Innovation Medical Research Council
  • Engineering and Physical Sciences Research Council
  • Brown University
  • National Science Foundation Graduate Research Fellowship Program
  • UK Regenerative Medicine Platform
  • National Institutes of Health

Zitieren

APA

Dwyer, K. D., Soepriatna, A. H., Snyder, C. A., Callanan, A., & Coulombe, K. L. K. (2026). A coordinated biomaterial strategy for post-infarction cardiac repair: integrating tailored mechanical reinforcement with hiPSC-derived cardiomyocytes in composite engineered human myocardium for remuscularization. Biomaterials, 327, 123727. https://doi.org/10.1016/j.biomaterials.2025.123727

Vancouver

Dwyer KD, Soepriatna AH, Snyder CA, Callanan A, Coulombe KLK. A coordinated biomaterial strategy for post-infarction cardiac repair: integrating tailored mechanical reinforcement with hiPSC-derived cardiomyocytes in composite engineered human myocardium for remuscularization. Biomaterials. 2026;327:123727. doi:10.1016/j.biomaterials.2025.123727

BibTeX
@article{Dwyer2026,
  author = {Dwyer, Kiera D and Soepriatna, Arvin H and Snyder, Caroline A and Callanan, Anthony and Coulombe, Kareen L K},
  title = {A coordinated biomaterial strategy for post-infarction cardiac repair: integrating tailored mechanical reinforcement with hiPSC-derived cardiomyocytes in composite engineered human myocardium for remuscularization},
  journal = {Biomaterials},
  year = {2026},
  volume = {327},
  pages = {123727},
  doi = {10.1016/j.biomaterials.2025.123727}
}
Kostenlos starten →